Biomarker Card
This biomarker card gives comprehensive information about each biomarker.
Detailed Information | |
---|---|
Biomarker ID | 1017 |
PMID | 23119026 |
Year | 2012 |
Biomarker | Spondin 2 (SPON2) |
Biomarker Basis | Methylation Based |
Biomolecule | Methylation |
Source | Tissue |
Subjects | Humans |
Regulation | Hypermethylation in PCa |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | Pathways include: Integrin beta-2 pathway |
Experiment | Pca Tumor Vs Tumor Adjacent |
Type of Biomarker | Diagnostic |
Cohort | PCa (n=19) and adjacent normal tissues (n=4) were used for discovery, and validated on additional 56 PCa samples and 55 adjacent normal tissues. [Results for validation set] |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | p = 2.1 x10^-14 |
Method Used | Bisulfate Sequencing |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Validated on independent patient dataset |
Technical Name | NA |